OCULAR PRESSURE-REDUCING AGENT CONTAINING COMPOUND WHICH HAS HISTONE DEACETYLASE INHIBITORY ACTION AS ACTIVE INGREDIENT
PROBLEM TO BE SOLVED: To provide a compound having a histone deacetylase (HDAC) inhibitory action and further having a new pharmacological action. SOLUTION: The compound having an HDAC inhibitory action has an excellent ability of changing the cytomorphology of trabecular cells and/or an excellent o...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | PROBLEM TO BE SOLVED: To provide a compound having a histone deacetylase (HDAC) inhibitory action and further having a new pharmacological action. SOLUTION: The compound having an HDAC inhibitory action has an excellent ability of changing the cytomorphology of trabecular cells and/or an excellent ocular hypotensive activity, and is accordingly useful as a prophylactic and/or therapeutic agent for a disease associated with aqueous humor circulation and/or ocular tension, particularly the prophylactic and/or therapeutic agent for glaucoma and ocular hypertension. COPYRIGHT: (C)2009,JPO&INPIT |
---|